NORDIC PHARMACEUTICAL COMPANY SAC — Enoxaparin Importer Profile
Pharmaceutical Importer · #13 buyer for Enoxaparin · $973.7K import value · 23 shipments · PERU · DGFT Verified
NORDIC PHARMACEUTICAL COMPANY SAC is the #13 importer of Enoxaparin from India with $973.7K in import value and 23 verified shipments. NORDIC PHARMACEUTICAL COMPANY SAC holds a 0.5% market share in Enoxaparin imports based in PERU. The company sources from 1 verified supplier across 14 formulations shipped to 1 country. Overall, NORDIC PHARMACEUTICAL COMPANY SAC imports 4 pharmaceutical products worth $7.3M across 3 therapeutic categories.
NORDIC PHARMACEUTICAL COMPANY SAC — Enoxaparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Enoxaparin to NORDIC PHARMACEUTICAL COMPANY SAC?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $973.7K | 23 | 100.0% |
NORDIC PHARMACEUTICAL COMPANY SAC sources Enoxaparin from 1 verified Indian supplier based on 23 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does NORDIC PHARMACEUTICAL COMPANY SAC Compare to Nearest Enoxaparin Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $1.1M | 22 | $50.0K |
| 6 | FRESENIUS KABI USA LLC, | UNITED STATES | $950.0K | 19 | $50.0K |
| 13 | NORDIC PHARMACEUTICAL COMPANY SAC ★ | PERU | $950.0K | 19 | $50.0K |
| 10 | EVERSANA EVERSANA | UNITED STATES | $650.0K | 13 | $50.0K |
| 9 | STATE PHARMACEUTICALS CORPORATION | SRI LANKA | $400.0K | 8 | $50.0K |
NORDIC PHARMACEUTICAL COMPANY SAC ranks #13 among 505 Enoxaparin importers from India. Average shipment value of $50.0K compared to the market average of $116.5K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES LLC and FRESENIUS KABI USA LLC,.
Where Does NORDIC PHARMACEUTICAL COMPANY SAC Import Enoxaparin To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $973.7K | 23 | 100.0% |
NORDIC PHARMACEUTICAL COMPANY SAC imports Enoxaparin to 1 country. The primary destination is PERU receiving 100.0% of shipments worth $973.7K.
What Enoxaparin Formulations Does NORDIC PHARMACEUTICAL COMPANY SAC Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 60MG IN 0.6ML PRE-FILLED SYRINGE | $343.8K | 8 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,40MG IN 0.4ML PRE-FILLED SYRINGE | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0.6ML PRE-FILLED SYRINGE | $89.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PRE-FILLED SYRINGE | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRING | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 60MG IN 0.6ML PRE-FILLED SYRINGE92880NOS | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE136480NOS | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,60MG IN 0.6ML PRE-FILLEDSYRINGE | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PRE FILLED SYRINGE | $50.0K | 1 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE | $46.6K | 1 |
NORDIC PHARMACEUTICAL COMPANY SAC imports 14 distinct Enoxaparin formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, with 8 shipments worth $343.8K.
Who Are the Top Buyers of Enoxaparin from India and How Much Does NORDIC PHARMACEUTICAL COMPANY SAC Import?
India exported $58.9M worth of Enoxaparin through 3,309 shipments from 223 suppliers to 118 countries, serving 505 buyers globally. NORDIC PHARMACEUTICAL COMPANY SAC imports $973.7K of this total, accounting for 0.5% of India's Enoxaparin exports with 23 shipments from PERU. This is verified from 23 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for NORDIC PHARMACEUTICAL COMPANY SAC's Enoxaparin Imports?
NORDIC PHARMACEUTICAL COMPANY SAC's average Enoxaparin order value is $42.3K per consignment, based on 23 shipments totaling $973.7K. NORDIC PHARMACEUTICAL COMPANY SAC is based in PERU and ranks #13 among all Enoxaparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Enoxaparin to NORDIC PHARMACEUTICAL COMPANY SAC?
NORDIC PHARMACEUTICAL COMPANY SAC sources Enoxaparin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($973.7K, 100.0%). This is based on 23 customs records.
How Does NORDIC PHARMACEUTICAL COMPANY SAC Compare to Other Enoxaparin Importers?
NORDIC PHARMACEUTICAL COMPANY SAC ranks #13 among 505 Enoxaparin importers from India with a 0.5% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($20.6M), BOSTON ONCOLOGY ARABIA ($12.8M), BE PHARMACEUTICALS INC ($6.9M). NORDIC PHARMACEUTICAL COMPANY SAC processed 23 shipments from PERU.
What Other Cardiovascular Products Does NORDIC PHARMACEUTICAL COMPANY SAC Import?
NORDIC PHARMACEUTICAL COMPANY SAC also imports these cardiovascular products. Each links to the detailed product page.
About NORDIC PHARMACEUTICAL COMPANY SAC
NORDIC PHARMACEUTICAL COMPANY SAC imports 4 products worth $7.3M. Beyond Enoxaparin, top products include Heparin, Sodium, Syringe. View the complete NORDIC PHARMACEUTICAL COMPANY SAC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Enoxaparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NORDIC PHARMACEUTICAL COMPANY SAC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NORDIC PHARMACEUTICAL COMPANY SAC's capped import value divided by total capped export value for Enoxaparin across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching NORDIC PHARMACEUTICAL COMPANY SAC importing Enoxaparin, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 505+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Enoxaparin Import Data for NORDIC PHARMACEUTICAL COMPANY SAC
Access order-level details, pricing data, supplier connections, and competitive analysis for NORDIC PHARMACEUTICAL COMPANY SAC's Enoxaparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NORDIC PHARMACEUTICAL COMPANY SAC
Full Company Profile →
4 products · $7.3M total trade · 3 categories
NORDIC PHARMACEUTICAL COMPANY SAC × Enoxaparin
Verified from customs records
Company Overview
Top Products by NORDIC PHARMACEUTICAL COMPANY SAC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NORDIC PHARMACEUTICAL COMPANY SAC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Enoxaparin. For current order-level data, contact TransData Nexus.